However, clinical trials may begin in the next decade, says Boyden, who is involved in a company, Eos, that aims to use optogenetics to treat blindness.
不过接下来的十年里可能会开展临床试验,鲍登如是说,他现在与Eos公司合作,该公司旨在用光遗传学治疗失明。
However, clinical trials may begin in the next decade, says Boyden, who is involved in a company, Eos, that aims to use optogenetics to treat blindness.
不过接下来的十年里可能会开展临床试验,鲍登如是说,他现在与Eos公司合作,该公司旨在用光遗传学治疗失明。
应用推荐